STOCK TITAN
  1. Home
  2. Sec-filings
  3. CLNN
  4. [144] Clene Inc. SEC Filing

Symbiosis II LLC lists CLNN sales (NASDAQ: CLNN) including 67,991-share lot

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Symbiosis II LLC reports multiple open-market sales of Common stock of CLNN recorded on Form 144. The filing lists numerous cash transactions from 01/28/2026 through 05/04/2026, including lots such as 67,991 shares on 03/31/2026 and 31,624 shares on 05/04/2026.

Positive

  • None.

Negative

  • None.
Sale on 03/31/2026 67,991 shares reported sale on 03/31/2026 with proceeds $332,103.67
Sale on 05/04/2026 31,624 shares reported sale on 05/04/2026 with proceeds $225,156.71
Sale on 04/21/2026 61,345 shares reported sale on 04/21/2026 with proceeds $376,718.05
Sale on 04/02/2026 24,925 shares reported sale on 04/02/2026 with proceeds $119,855.20
Sale on 03/27/2026 17,470 shares reported sale on 03/27/2026 with proceeds $82,908.17
Open Market Purchase market
"Common | 09/30/2024 | Open Market Purchase | Issuer"
An open market purchase is when a company buys its own shares on public stock exchanges the same way any investor would, rather than through a private deal. Investors care because these purchases reduce the number of shares available, can boost earnings per share and share price, signal that management thinks the stock is undervalued, and use company cash that might otherwise go to reinvestment or dividends — like a business quietly buying back its own tickets at the box office.
Common market
"Common | Merrill Lynch 555 California St Ste 1800 San Francisco CA 94104"
Cash other
"09/30/2024 | Open Market Purchase | Issuer | | | 297066 | 09/30/2024 | Cash"

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR

FAQ

What does CLNN Form 144 filed by Symbiosis II LLC show?

It lists open-market cash sales of Common stock by Symbiosis II LLC. The filing itemizes individual trades by date, share count, and cash proceeds between 01/28/2026 and 05/04/2026, including several large lots.

How many shares were sold on CLNN on 03/31/2026?

The filing reports 67,991 shares sold on 03/31/2026. That line shows the sale and the associated cash proceeds of $332,103.67 for that lot as disclosed in the filing.

What size sale is reported on CLNN for 05/04/2026?

The filing shows a 31,624-share sale on 05/04/2026. That transaction is recorded with cash proceeds of $225,156.71 in the itemized sales listed in the filing.

Are the transactions in the filing described as open-market or private?

The filing identifies the trades as "Open Market Purchase" method and records cash as the consideration. Each itemized line includes a trade date, share count, and cash proceeds indicating public market transactions.

Who is the reporting seller in the CLNN Form 144?

The reported selling entity is Symbiosis II LLC. The filing lists that entity's address and the sequence of Common stock sales across the listed dates and amounts in the filing.